Comparison between Gibson-Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive Diagnosis.
CRMS/CFSPID
Gibson–Cooke method
QNS
cystic fibrosis outcome
macroduct system-based method
sweat test
Journal
International journal of neonatal screening
ISSN: 2409-515X
Titre abrégé: Int J Neonatal Screen
Pays: Switzerland
ID NLM: 101665400
Informations de publication
Date de publication:
25 Jul 2023
25 Jul 2023
Historique:
received:
19
04
2023
revised:
27
06
2023
accepted:
21
07
2023
medline:
22
8
2023
pubmed:
22
8
2023
entrez:
22
8
2023
Statut:
epublish
Résumé
The sweat test (ST) is the current diagnostic gold standard for cystic fibrosis (CF). Many CF centres have switched from the Gibson-Cooke method to the Macroduct system-based method. We used these methods simultaneously to compare CF screening outcomes. STs using both methods were performed simultaneously between March and December 2022 at CF Centre in Florence. We included newborns who underwent newborn bloodspot screening (NBS), newborns undergoing transfusion immediately after birth, and children with CF screen-positive, inconclusive diagnosis (CFSPID). We assessed 72 subjects (median age 4.4 months; range 0-76.7): 30 (41.7%) NBS-positive, 18 (25.0%) newborns who underwent transfusion, and 24 (33.3%) children with CFSPID. No significant differences were found between valid sample numbers, by patient ages and groups (
Identifiants
pubmed: 37606478
pii: ijns9030041
doi: 10.3390/ijns9030041
pmc: PMC10443242
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fondazione per la Ricerca sulla Fibrosi Cistica
ID : FFC#30/2018; FFC#24/2020
Références
Children (Basel). 2023 Jan 18;10(2):
pubmed: 36832306
Lancet Respir Med. 2020 Jan;8(1):65-124
pubmed: 31570318
Clin Biochem. 2016 May;49(7-8):601-5
pubmed: 26851350
Arch Dis Child. 1984 Oct;59(10):919-22
pubmed: 6497428
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Clin Biochem. 2005 Oct;38(10):934-7
pubmed: 15953599
J Pediatr. 2017 Feb;181S:S4-S15.e1
pubmed: 28129811
J Paediatr Child Health. 2006 Apr;42(4):153-4
pubmed: 16630312
Acta Paediatr. 2000 Aug;89(8):933-7
pubmed: 10976833
Pediatrics. 2021 Dec 1;148(6):
pubmed: 34814176
J Pediatr. 2017 Feb;181S:S45-S51.e1
pubmed: 28129812
J Pediatr. 1996 Dec;129(6):892-7
pubmed: 8969732
Ann Clin Biochem. 2007 Jan;44(Pt 1):25-34
pubmed: 17270089
J Cyst Fibros. 2021 Sep;20(5):828-834
pubmed: 33883100
J Pediatr. 1994 Feb;124(2):255-60
pubmed: 8301433
Pediatr Pulmonol. 2011 Dec;46(12):1166-74
pubmed: 22081556
J Pediatr. 2007 Jul;151(1):85-9
pubmed: 17586196
Pediatr Pulmonol. 2021 Dec;56(12):3785-3791
pubmed: 34549893
Pediatrics. 2009 Feb;123(2):e338-46
pubmed: 19171585
Paediatr Respir Rev. 2004;5 Suppl A:S357-9
pubmed: 14980295
Ital J Pediatr. 2021 Jan 6;47(1):2
pubmed: 33407736
J Cyst Fibros. 2021 Sep;20(5):810-819
pubmed: 33257262
J Cyst Fibros. 2019 Jul;18(4):484-490
pubmed: 31005549
Eur J Hum Genet. 2022 May;30(5):520-531
pubmed: 35256770
Pediatr Pulmonol. 2023 Apr;58(4):1074-1084
pubmed: 36582049
J Cyst Fibros. 2022 May;21(3):434-441
pubmed: 35063396
Int J Environ Res Public Health. 2020 May 04;17(9):
pubmed: 32375358
Clin Biochem. 2009 Aug;42(12):1260-4
pubmed: 19445912
J Cyst Fibros. 2023 May;22(3):420-426
pubmed: 36528525
Pediatrics. 1959 Mar;23(3):545-9
pubmed: 13633369
J Pediatr. 2008 Aug;153(2):S4-S14
pubmed: 18639722
Pediatr Pulmonol. 2005 Jun;39(6):507-11
pubmed: 15830391